Gene and cell therapy based treatment strategies for inflammatory bowel diseases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

544

HTML

5441

Figures (1-1)

219

Tables (1-2)

177

Sum=6381

Dec 15, 2011 (publication date) through Jul 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pathophysiol. Dec 15, 2011; 2(6): 114-122
Published online Dec 15, 2011. doi: 10.4291/wjgp.v2.i6.114

Table 1 Overview of the gene therapy based treatment strategies for inflammatory bowel diseases as discussed in this review

	Viral vector	Gut targeting	Reference for gut targeting	Status of development	Reference for status of development
Gene therapy	Retro- and lentiviral	Yes	[24-27]	Not performed	N/A
	Adenoviral	Yes	[28-30]	Preclinical	[28-30]
	AAV	Yes	[31,32]	Not performed	N/A

The status of development refers to research which has already been performed. AAV: Adeno-associated virus; N/A: Not applicable.

Citation: Marel SVD, Majowicz A, Deventer SV, Petry H, Hommes DW, Ferreira V. Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol 2011; 2(6): 114-122
URL: https://www.wjgnet.com/2150-5330/full/v2/i6/114.htm
DOI: https://dx.doi.org/10.4291/wjgp.v2.i6.114